| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.8 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.22 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |